FLUOROURACIL cream

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

FLUOROURACIL (UNII: U3P01618RT) (FLUOROURACIL - UNII:U3P01618RT)

Available from:

Mylan Pharmaceuticals Inc.

INN (International Name):

Fluorouracil

Composition:

Fluorouracil 5 mg in 1 g

Administration route:

TOPICAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Fluorouracil 5% Topical Cream is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Safety and efficacy in other indications have not been established. The diagnosis should be established prior to treatment, since this method has not been proven effective in other types of basal cell carcinomas. With isolated, easily accessible basal cell carcinomas, surgery is preferred since success with such lesions is almost 100%. The success rate with Fluorouracil 5% Topical Cream is approximately 93%, based on 113 lesions in 54 patients. Twenty-five lesions treated with the solution produced 1 failure and 88 lesions treated with the cream produced 7 failures. Fluorouracil 5% Topical Cream may cause fetal harm when administered to a pregnant woman. There are no adequate and well-controlled studies in pr

Product summary:

Fluorouracil 5% Topical Cream is available in 40 g tubes containing 5% fluorouracil (NDC 0378-4791-06) in a vanishing cream base consisting of methylparaben, polysorbate 60, propylene glycol, propylparaben, purified water, stearyl alcohol, and white petrolatum. Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. 1337.3 Revised: 6/2021 FLUOR:R3

Authorization status:

New Drug Application Authorized Generic

Summary of Product characteristics

FLUOROURACIL- FLUOROURACIL CREAM
MYLAN PHARMACEUTICALS INC.
----------
DESCRIPTION
Fluorouracil 5% Topical Cream is a topical preparation containing the
fluorinated
pyrimidine 5-fluorouracil, an antineoplastic antimetabolite.
Fluorouracil 5% Topical Cream contains 5% fluorouracil in a vanishing
cream base
consisting of methylparaben, polysorbate 60, propylene glycol,
propylparaben, purified
water, stearyl alcohol, and white petrolatum.
Chemically, fluorouracil is a 5-fluoro-2,4(1_H_,3_H_)-pyrimidinedione.
It is a white to
practically white crystalline powder which is sparingly soluble in
water and slightly soluble
in alcohol. One gram of fluorouracil is soluble in 100 mL of propylene
glycol. The
molecular weight of 5-fluorouracil is 130.08 and the structural
formula is:
CLINICAL PHARMACOLOGY
There is evidence that the metabolism of fluorouracil in the anabolic
pathway blocks the
methylation reaction of deoxyuridylic acid to thymidylic acid. In this
manner, fluorouracil
interferes with the synthesis of deoxyribonucleic acid (DNA) and to a
lesser extent
inhibits the formation of ribonucleic acid (RNA). Since DNA and RNA
are essential for cell
division and growth, the effect of fluorouracil may be to create a
thymine deficiency
which provokes unbalanced growth and death of the cell. The effects of
DNA and RNA
deprivation are most marked on those cells which grow more rapidly and
take up
fluorouracil at a more rapid rate. The catabolic metabolism of
fluorouracil results in
degradation products (e.g., CO , urea, α-fluoro-β-alanine) which are
inactive.
Systemic absorption studies of topically applied fluorouracil have
been performed on
patients with actinic keratoses using tracer amounts of
C-labeled fluorouracil added to
a 5% preparation. All patients had been receiving nonlabeled
fluorouracil until the peak of
the inflammatory reaction occurred (2 to 3 weeks), ensuring that the
time of maximum
absorption was used for measurement. One gram of labeled preparation
was applied to
the entire face and neck and left in pl